HF/Transplantation

Top Story

Prinston Pharmaceutical recalls irbesartan for impurity in active pharmaceutical ingredient

January 21, 2019
In the Journals

Spironolactone effective as HFpEF treatment regardless of kidney function, but safety less clear

January 17, 2019
The efficacy of spironolactone in patients with HF with preserved ejection fraction was consistent across the range of kidney function, although adverse events were…
In the Journals

Almost 16% of pediatric transplant recipients hospitalized with vaccine-preventable diseases

January 15, 2019
Children receiving solid organ transplants — especially lung, heart, intestine and multivisceral transplants — are hospitalized with vaccine-preventable…
In the Journals

Improved medical therapy may lead to better outcomes in treating HFrEF

January 15, 2019
An increased emphasis in improvement of medical therapy in patients with HF with reduced ejection fraction may lead to better outcomes, according to JACC: Heart
More Headlines »
CME

Providing Quality Care for Patients with Heart Failure

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Heart failure (HF) affects as many as 6 million adults in the United States, and the prevalence is anticipated to
More »
Video
Meeting News

VIDEO: New treatment option for rare cardiomyopathy may 'change lives'

September 15, 2018
More »
Video
Meeting News

VIDEO: Focus on heart failure prevention warranted in patients with diabetes

July 15, 2018
More »